{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:04:39Z","timestamp":1761743079386},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2008,3,5]],"date-time":"2008-03-05T00:00:00Z","timestamp":1204675200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Urologe"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1007\/s00120-008-1671-z","type":"journal-article","created":{"date-parts":[[2008,3,3]],"date-time":"2008-03-03T16:05:24Z","timestamp":1204560324000},"page":"608-615","source":"Crossref","is-referenced-by-count":5,"title":["Vergleich der Effektivit\u00e4t der Langzeitinstillation mit Mitomycin\u00a0C gegen Kurzzeitprophylaxen mit MMC oder Bacillus Calmette-Guerin"],"prefix":"10.1007","volume":"47","author":[{"given":"H.","family":"Isbarn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Bud\u00e4us","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Pichlmeier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Conrad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Huland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.G.","family":"Friedrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,3,5]]},"reference":[{"key":"1671_CR1","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0302-2838(02)00466-9","volume":"42","author":"Chopin","year":"2002","unstructured":"Chopin DK, Gattegno B (2002) Superficial bladder tumors. Eur Urol 42: 533\u2013541","journal-title":"Eur Urol"},{"key":"1671_CR2","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","volume":"49","author":"Sylvester","year":"2006","unstructured":"Sylvester RJ, Meijden AP van der, Oosterlinck W et al. (2006) Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 49: 466\u2013477","journal-title":"Eur Urol"},{"key":"1671_CR3","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0022-5347(05)67975-X","volume":"163","author":"Millan-Rodriguez","year":"2000","unstructured":"Millan-Rodriguez F, Chechile-Toniolo G, Salvador-Bayarri J et al. (2000) Multivariate analysis of the prognostic factors of primary superficial bladder cancer. J Urol 163: 73\u201378","journal-title":"J Urol"},{"key":"1671_CR4","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/S0022-5347(05)68208-0","volume":"162","author":"Smith","year":"1999","unstructured":"Smith JA Jr, Labasky RF, Cockett AT et al. (1999) Bladder cancer clinical guidelines panel summary report on the management of nonmuscle invasive bladder cancer (stages Ta, T1 and TIS). The American Urological Association. J Urol 162: 1697\u20131701","journal-title":"J Urol"},{"key":"1671_CR5","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0022-5347(17)39368-0","volume":"144","author":"Huland","year":"1990","unstructured":"Huland H, Kloppel G, Feddersen I et al. (1990) Comparison of different schedules of cytostatic intravesical instillations in patients with superficial bladder carcinoma: final evaluation of a prospective multicenter study with 419 patients. J Urol 144: 68\u201372","journal-title":"J Urol"},{"key":"1671_CR6","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/S0022-5347(01)67608-0","volume":"153","author":"Bouffioux","year":"1995","unstructured":"Bouffioux C, Kurth KH, Bono A et al. (1995) Intravesical adjuvant chemotherapy for superficial transitional cell bladder carcinoma: results of 2 EORTC randomized trials with Mitomycin C and doxurubicin comparing early vs, delayed instillations and short-term vs. long-term treatment. EORTC Genitourinary Group. J Urol 153: 934\u2013941","journal-title":"J Urol"},{"key":"1671_CR7","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/S0022-5347(01)61607-0","volume":"161","author":"Malmstr\u00f6m","year":"1999","unstructured":"Malmstr\u00f6m PU, Wijkstr\u00f6m H, Lundholm C et al. (1999) 5-year followup of a randomized prospective study comparing Mitomycin C and bacillus Calmette-Guerin in patients with superficial bladder carcinoma. Swedish-Norwegian Bladder Cancer Study Group. J Urol 161: 1124\u20131127","journal-title":"J Urol"},{"key":"1671_CR8","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/S0022-5347(01)65673-8","volume":"156","author":"Krege","year":"1996","unstructured":"Krege S, Giani G, Meyer R et al. (1996) A randomized multicenter trial of adjuvant therapy in superficial bladder cancer: transurethral resection only vs. transurethral resection plus Mitomycin C vs. transurethral resection plus bacillus Calmette-Guerin. J Urol 156: 962\u2013966","journal-title":"J Urol"},{"key":"1671_CR9","first-page":"1161","volume":"12","author":"Oosterlinck","year":"2002","unstructured":"Oosterlinck W, Lobel B, Jackse G et al. (2002) EAU Recommendations 2001. \u201eGuidelines on bladder cancer\u201c. Prog Urol 12: 1161\u20131163","journal-title":"Prog Urol"},{"key":"1671_CR10","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/S0022-5347(05)64273-5","volume":"168","author":"Sylvester","year":"2002","unstructured":"Sylvester RJ, Meijden AP van der, Lamm DL (2002) Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials. J Urol 168: 1964\u20131970","journal-title":"J Urol"},{"key":"1671_CR11","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.urology.2003.11.049","volume":"63","author":"B\u00f6hle","year":"2004","unstructured":"B\u00f6hle A, Bock PR (2004) Intravesical bacille Calmette-Guerin versus Mitomycin C in superficial bladder cancer: formal meta-analysis of comparative studies on tumor progression. Urology 63: 682\u2013687","journal-title":"Urology"},{"key":"1671_CR12","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0022-5347(05)64043-8","volume":"169","author":"B\u00f6hle","year":"2003","unstructured":"B\u00f6hle A, Jocham D, Bock PR (2003) Intravesical bacillus Calmette-Guerin versus Mitomycin C for superficial bladder cancer: a formal meta-analysis of comparative studies on recurrence and toxicity. J Urol 169: 90\u201395","journal-title":"J Urol"},{"key":"1671_CR13","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.eururo.2006.01.017","volume":"49","author":"Witjes","year":"2006","unstructured":"Witjes JA (2006) Management of BCG failures in superficial bladder cancer: a review. Eur Urol 49: 790\u2013797","journal-title":"Eur Urol"},{"key":"1671_CR14","doi-asserted-by":"crossref","unstructured":"Sobin DHWC (2002) TNM classification of malignant tumors, 6th edn. Wiley-Liss, New York","DOI":"10.1002\/0471463752"},{"key":"1671_CR15","unstructured":"Oosterlinck W, Meijden AP van der, Sylvester R et al. (2006) Guidelines on TaT1 (non-muscle invasive) bladder cancer. EAU Recommendations, Arnhem, Niederlande"},{"key":"1671_CR16","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/01.coc.0000135570.37287.7f","volume":"27","author":"Huncharek","year":"2004","unstructured":"Huncharek M, Kupelnick B (2004) The influence of intravesical therapy on progression of superficial transitional cell carcinoma of the bladder: a metaanalytic comparison of chemotherapy versus bacilli Calmette-Guerin immunotherapy. Am J Clin Oncol 27: 522\u2013528","journal-title":"Am J Clin Oncol"},{"key":"1671_CR17","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0022-5347(01)65853-1","volume":"156","author":"Lundholm","year":"1996","unstructured":"Lundholm C, Norlen BJ, Ekman P et al. (1996) A randomized prospective study comparing long-term intravesical instillations of Mitomycin C and bacillus Calmette-Guerin in patients with superficial bladder carcinoma. J Urol 156: 372\u2013376","journal-title":"J Urol"},{"key":"1671_CR18","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/1078-1439(95)00041-F","volume":"1","author":"Lamm","year":"1995","unstructured":"Lamm DL, Blumenstein BA, Crawford ED et al. (1995) Randomized intergroup comparison of bacillus Calmette-Guerin immunotherapy and Mitomycin C chemotherapy prophylaxis in superficial transitional cell carcinoma of the bladder. A Sothwest Oncology Group Study. Urol Oncol 1: 119\u2013124","journal-title":"Urol Oncol"},{"key":"1671_CR19","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1046\/j.1464-410X.2003.04357.x","volume":"92","author":"Evans","year":"2003","unstructured":"Evans CP, Busby JE (2003) The management of stage T1 grade 3 transitional cell carcinoma of the bladder. BJU Int 92: 345\u2013348","journal-title":"BJU Int"},{"key":"1671_CR20","unstructured":"Lamm DL (1995) BCG immunotherapy for transitional-cell carcinoma in situ of the bladder. Oncology (Huntingt) 9: 947\u2013965"},{"key":"1671_CR21","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0090-4295(98)00212-X","volume":"52","author":"Witjes","year":"1998","unstructured":"Witjes JA, Meijden AP van der, Collette L et al. (1998) Long-term follow-up of an EORTC randomized prospective trial comparing intravesical bacille Calmette-Guerin-RIVM and Mitomycin C in superficial bladder cancer. EORTC GU Group and the Dutch South East Cooperative Urological Group. European Organisation for Research and Treatment of Cancer Genito-Urinary Tract Cancer Collaborative Group. Urology 52: 403\u2013410","journal-title":"Urology"},{"key":"1671_CR22","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/j.1464-410X.2006.06706.x","volume":"4","author":"Gardmark","year":"2007","unstructured":"Gardmark T, Jahnson S, Wahlquist R et al. (2007) Analysis of progression and survival after 10 years of a randomized prospective study comparing Mitomycin-C and bacillus Calmette-Guerin in patients with high-risk bladder cancer. BJU Int 4: 817\u2013820","journal-title":"BJU Int"},{"key":"1671_CR23","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/jnci\/93.8.597","volume":"93","author":"Au","year":"2001","unstructured":"Au JL, Badalament RA, Wientjes MG et al. (2001) Methods to improve efficacy of intravesical Mitomycin C: results of a randomized phase III trial. J Natl Cancer Inst 93: 597\u2013604","journal-title":"J Natl Cancer Inst"},{"key":"1671_CR24","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1097\/01.ju.0000125486.92260.b2","volume":"171","author":"Sylvester","year":"2004","unstructured":"Sylvester RJ, Oosterlinck W, Meijden AP van der (2004) A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta, T1 bladder cancer: a meta-analysis of published results of randomized clinical trials. J Urol 171: 2186\u20132435","journal-title":"J Urol"}],"container-title":["Der Urologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-008-1671-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00120-008-1671-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-008-1671-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T10:58:50Z","timestamp":1558609130000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00120-008-1671-z"}},"subtitle":["Untersuchung bei Patienten mit nicht muskelinvasivem Urothelkarzinom der Harnblase"],"short-title":[],"issued":{"date-parts":[[2008,3,5]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["1671"],"URL":"https:\/\/doi.org\/10.1007\/s00120-008-1671-z","relation":{},"ISSN":["0340-2592","1433-0563"],"issn-type":[{"value":"0340-2592","type":"print"},{"value":"1433-0563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,3,5]]}}}